tiprankstipranks
RenovoRx (RNXT)
NASDAQ:RNXT
US Market

RenovoRx (RNXT) Financial Statements

53 Followers

RenovoRx Financial Overview

RenovoRx's market cap is currently ―. The company's EPS TTM is $-0.725; its P/E ratio is -1.54; RenovoRx is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 2.51M$ -2.98M$ -2.33M$ 3.27M$ -2.17M
EBITDA$ 2.51M$ -2.98M$ -2.33M$ 3.27M$ -2.17M
Net Income Common Stockholders$ -1.08M$ -1.42M$ -2.33M$ 3.27M$ -2.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.40M$ 3.20M$ 6.00M$ 3.70M$ 6.44M
Total Assets$ 4.79M$ 3.52M$ 6.31M$ 4.56M$ 7.26M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -4.40M$ -3.20M$ -6.00M$ -3.70M$ -6.44M
Total Liabilities$ 3.02M$ 3.51M$ 5.13M$ 1.30M$ 1.10M
Stockholders Equity$ 1.77M$ 6.00K$ 1.19M$ 3.26M$ 6.16M
Cash Flow-
Free Cash Flow$ -2.20M$ -2.73M$ -2.77M$ -2.71M$ -1.68M
Operating Cash Flow$ -2.20M$ -2.73M$ -2.77M$ -2.71M$ -1.68M
Investing Cash Flow---$ 2.03M$ 2.98M
Financing Cash Flow$ 5.42M-$ 5.00M$ 6.00K$ 3.00K
Currency in USD

RenovoRx Earnings and Revenue History

RenovoRx Debt to Assets

RenovoRx Cash Flow

RenovoRx Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis